B. Mark Smithers
B. Mark Smithers
Verified email at
Cited by
Cited by
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
KM Sjoquist, BH Burmeister, BM Smithers, JR Zalcberg, RJ Simes, ...
The lancet oncology 12 (7), 681-692, 2011
Final trial report of sentinel-node biopsy versus nodal observation in melanoma
DL Morton, JF Thompson, AJ Cochran, N Mozzillo, OE Nieweg, DF Roses, ...
New England Journal of Medicine 370 (7), 599-609, 2014
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
V Gebski, B Burmeister, BM Smithers, K Foo, J Zalcberg, J Simes
The lancet oncology 8 (3), 226-234, 2007
Completion dissection or observation for sentinel-node metastasis in melanoma
MB Faries, JF Thompson, AJ Cochran, RH Andtbacka, N Mozzillo, ...
New England Journal of Medicine 376 (23), 2211-2222, 2017
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, ...
The lancet oncology 6 (9), 659-668, 2005
International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG)
DE Low, D Alderson, I Cecconello, AC Chang, GE Darling, XB D'Journo, ...
Annals of surgery 262 (2), 286-294, 2015
Benchmarking complications associated with esophagectomy
DE Low, MK Kuppusamy, D Alderson, I Cecconello, AC Chang, G Darling, ...
Annals of surgery 269 (2), 291-298, 2019
Comparison of the outcomes between open and minimally invasive esophagectomy
BM Smithers, DC Gotley, I Martin, JM Thomas
Annals of surgery 245 (2), 232-240, 2007
Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
DE Low, W Allum, G De Manzoni, L Ferri, A Immanuel, MK Kuppusamy, ...
World journal of surgery 43, 299-330, 2019
Worldwide esophageal cancer collaboration
TW Rice, VW Rusch, C Apperson-Hansen, MS Allen, LQ Chen, JG Hunter, ...
Diseases of the Esophagus 22 (1), 1-8, 2009
High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’screening of hypertensive patients
M Stowasser, RD Gordon, TG Gunasekera, DC Cowley, G Ward, ...
Journal of hypertension 21 (11), 2149-2157, 2003
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
BH Burmeister, JM Thomas, EA Burmeister, ET Walpole, JA Harvey, ...
European journal of cancer 47 (3), 354-360, 2011
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus
DC Whiteman, S Sadeghi, N Pandeya, BM Smithers, DC Gotley, CJ Bain, ...
Gut 57 (2), 173-180, 2008
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
BH Burmeister, MA Henderson, J Ainslie, R Fisher, J Di Iulio, BM Smithers, ...
The lancet oncology 13 (6), 589-597, 2012
Laparoscopic versus open appendectomy: prospective randomized trial
JB Hansen, BM Smithers, D Schache, DR Wall, BJ Miller, BL MenZies
World journal of surgery 20, 17-21, 1996
Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002
M Coory, P Baade, J Aitken, M Smithers, GRC McLeod, I Ring
Cancer Causes & Control 17, 21-27, 2006
Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis
K Nones, N Waddell, N Wayte, AM Patch, P Bailey, F Newell, O Holmes, ...
Nature communications 5 (1), 5224, 2014
TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results from an …
T Leong, BM Smithers, K Haustermans, M Michael, V Gebski, D Miller, ...
Annals of surgical oncology 24, 2252-2258, 2017
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02 …
MA Henderson, BH Burmeister, J Ainslie, R Fisher, J Di Iulio, BM Smithers, ...
The Lancet Oncology 16 (9), 1049-1060, 2015
Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer
U Zingg, BM Smithers, DC Gotley, G Smith, A Aly, A Clough, AJ Esterman, ...
Annals of surgical oncology 18, 1460-1468, 2011
The system can't perform the operation now. Try again later.
Articles 1–20